Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin' Clinical Research Center for Cancer, Tianjin, China.
Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin' Clinical Research Center for Cancer, Tianjin, China.
Pathol Res Pract. 2018 Jan;214(1):72-75. doi: 10.1016/j.prp.2017.11.010. Epub 2017 Nov 16.
Cyclin D1, generally considered to be absent in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), has been reported in the proliferation centres (PCs) of recent CLL/SLL cases. Cyclin D1 immunostaining in CLL/SLL may lead to diagnostic confusion. The objective of this study was to identify the types of stained cells and the impact on diagnosis.
Cyclin D1 expression was assessed by immunostaining samples from 46 cases of CLL/SLL. CD68 and double immunostaining with CD20/CyclinD1, CD68/CyclinD1, and CD163/CyclinD1 were then performed in cases of CLL/SLL positive for cyclinD1 in the PCs.
Dim-positive cyclin D1 staining in randomly scattered cells in the CLL/SLLs were observed in 38/46 cases (82.6%). In five (10.9%) cases, more than 50 cyclin D1-positive cells per high-power field were detected within the PCs in CLL/SLL with weak to moderate intensity. Double immunochemical staining in these cases showed that cyclin D1 in these positive cells was mostly co-expressed with CD68 and CD163 and the cells were negative for CD20.
The cyclin D1-positive CLL/SLL cells in this study were mostly histiocytes. The expression of cyclin D1 by histiocytes may mimic cyclin D1+ CLL/SLL; thus, the recognition of cyclin D1 expression by non-lymphoid cells in lymphoma is important.
细胞周期蛋白 D1 通常被认为不存在于慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 (CLL/SLL) 中,但在最近的 CLL/SLL 病例的增殖中心 (PC) 中已有报道。CLL/SLL 中的细胞周期蛋白 D1 免疫染色可能导致诊断混淆。本研究的目的是确定染色细胞的类型及其对诊断的影响。
通过免疫染色 46 例 CLL/SLL 样本评估细胞周期蛋白 D1 的表达。然后在 PC 中细胞周期蛋白 D1 阳性的 CLL/SLL 病例中进行 CD68 和 CD20/CyclinD1、CD68/CyclinD1 和 CD163/CyclinD1 的双重免疫染色。
在 38/46 例 (82.6%) CLL/SLL 中观察到随机散在细胞中的弱阳性 Cyclin D1 染色。在 5 例 (10.9%) 病例中,在弱至中度强度的 CLL/SLL 的 PC 中检测到超过 50 个细胞周期蛋白 D1 阳性细胞/高倍视野。在这些病例中进行双重免疫化学染色显示,这些阳性细胞中的细胞周期蛋白 D1 主要与 CD68 和 CD163 共表达,而细胞对 CD20 呈阴性。
本研究中细胞周期蛋白 D1 阳性的 CLL/SLL 细胞大多为组织细胞。组织细胞表达细胞周期蛋白 D1 可能模拟细胞周期蛋白 D1+CLL/SLL;因此,识别淋巴瘤中非淋巴细胞中细胞周期蛋白 D1 的表达很重要。